References
- Buchholz U J, Finke S, Conzelmann K ‐K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BSRV genome promoter. J. Virol 1999; 73: 251–259
- Charlton K M, Casey G A. Experimental rabies in skunks: Immunofluorescent, light and electron microscopic studies. Lab Invest 1979; 41: 36–44
- Dietzschold B, Wunner W H, Wiktor T J, Lopes A S, Lafon M, Smith C L, Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 1983; 80: 70–74
- Dietzschold B, Wiktor T K, Trojanowski J Q, Macfarlan R I, Wunner W H, Torres‐Anjel M J, Koprowski H. Differences in cell‐to‐cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J. Virol 1985; 56: 12–18
- Habel K. Laboratory Techniques in Rabies. Monograph Series No. 23, World Health Organization, Geneva 1996; 321–335
- Kucera P, Dolivo M, Coulon P, Flamand A. Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain. J. Virol 1985; 55: 158–162
- Lawson K F, Hertler R, Charlton K M, Campbell J B, Rhodes A J. Safety and immunogenicity of ERA strains of rabies virus propagated in a BHK‐21 cell line. Can J Vet Res 1989; 53: 438–444
- Lentz T L, Hawrot E, Wilson P T. Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor. Proteins Struct Fund Genet 1987; 2: 298–307
- Mebatsion T, Conzelmann K ‐K. Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV‐1 envelope spike protein. Proc Natl Acad Sci USA 1996a; 93: 11366–11370
- Mebatsion T, Konig M, Conzelmann K ‐K. Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 1996b; 84: 941–951
- Mebatsion T, Weiland F, Conzelmann K ‐K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet‐shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol 1999; 73: 242–250
- Morimoto K, Hooper D C, Carbaugh H, Fu Z F, Koprowski H, Dietzschold B. Rabies virus quasispecies: Implications for pathogenesis. Proc Natl Acad Sci USA 1998; 95: 3152–3156
- Morimoto K, Hooper D C, Spitsin S, Koprowski H, Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol 1999; 73: 510–518
- Robinson C S, Whitt M A. The membrane‐proximal stem region of vesicular stomatitis virus G confers efficient virus assembly. J. Virol 2000; 74: 2239–2246
- Schnell M J, Mebatsion T, Conzelmann K ‐K. Infectious rabies virus from cloned cDNA. EMBO J 1994; 13: 4195–4203
- Seif I, Coulon P, Rollin P E, Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol 1985; 53: 926–934
- Thoulouze M ‐I, Lafage M, Montano‐Hirose J A, Lafon M. Rabies virus infects mouse and human lymphocytes and induces apoptosis. J. Virol 1997; 71: 7372–7380
- Thoulouze M ‐I, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol 1998; 72: 7181–7190
- Tuffereau C, Benejean J, Blondel D, Kieffer B, Flammand A. Low‐affinity nerve‐growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J 1998; 17: 7250–7259
- Wiktor T J, MacFarlan R I, Foggin C M, Koprowski H. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Dev Biol Stand 1984; 57: 199–221
- Yang C, Jackson A L. Basis of neurovirulent rabies virus variant AvOl with stereotaxic brain inoculation in mice. J. Gen Virol 1992; 73: 895–900